바이오인

The biopharmaceutical industry contributes significantly to national, state, and local economies. Recognizing this sector’s contributions to state economies in terms of providing high‐value, high‐wage, revenue‐generating jobs, PhRMA commissioned Battelle to conduct this study to examine the extent to which state governments are targeting the industry for economic growth and development. This report documents the range of state policies and initiatives designed to attract and grow the biopharmaceutical sector. The report was not meant to draw comparisons across states nor was it intended to suggest that there is a “model” approach or blueprint for attracting and building biopharmaceutical industry presence. Rather it highlights some effective approaches that other states may wish to consider as they develop their own economic development and innovation strategies. The report describes how states vary greatly in the maturity of their biopharmaceutical sectors and the degree to which state governments haves been involved in nurturing the growth of the industry. It also documents the economic value this sector offers and describes a range of policies that states can employ to create a climate favorable to sustaining and growing
this sector.